Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion.

Bieber M, Gronewold J, Scharf AC, Schuhmann MK, Langhauser F, Hopp S, Mencl S, Geuss E, Leinweber J, Guthmann J, Doeppner TR, Kleinschnitz C, Stoll G, Kraft P, Hermann DM.

Stroke. 2019 Oct;50(10):2875-2882. doi: 10.1161/STROKEAHA.119.026652. Epub 2019 Aug 15.

PMID:
31412755
2.

Tuberculosis in the European Union/European Economic Area: much progress, still many challenges.

Guthmann JP, Haas W.

Euro Surveill. 2019 Mar;24(12). doi: 10.2807/1560-7917.ES.2019.24.12.1900174. No abstract available.

3.

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient.

Helbling P, Kröger S, Haas W, Brusin S, Cirillo DM, Groenheit R, Guthmann JP, Soini H, Hendrickx D, van der Werf MJ.

Clin Microbiol Infect. 2018 Aug;24(8):918-919. doi: 10.1016/j.cmi.2018.03.015. Epub 2018 Mar 17. No abstract available.

4.

Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012.

Guthmann JP, Pelat C, Célant N, Parent du Chatelet I, Duport N, Rochereau T, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2017 Apr;65(2):109-117. doi: 10.1016/j.respe.2017.01.100. Epub 2017 Feb 24.

PMID:
28238476
5.

Blocking of platelet glycoprotein receptor Ib reduces "thrombo-inflammation" in mice with acute ischemic stroke.

Schuhmann MK, Guthmann J, Stoll G, Nieswandt B, Kraft P, Kleinschnitz C.

J Neuroinflammation. 2017 Jan 21;14(1):18. doi: 10.1186/s12974-017-0792-y.

6.

[Vaccination coverage and socioeconomic determinants of BCG vaccination in children before 3 months: Results of the Elfe cohort study, 2011].

Guthmann JP, Ragot M, Ben Boutieb M, Bois C, Dufourg MN, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2016 Sep;64(4):271-80. doi: 10.1016/j.respe.2016.06.001. Epub 2016 Aug 21. French.

PMID:
27553256
7.

The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety.

Fonteneau L, Ragot M, Parent du Châtelet I, Guthmann JP, Lévy-Bruhl D.

BMC Public Health. 2015 Dec 12;15:1233. doi: 10.1186/s12889-015-2575-7.

8.

Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.

WWARN Parasite Clearance Study Group, Abdulla S, Ashley EA, Bassat Q, Bethell D, Björkman A, Borrmann S, D'Alessandro U, Dahal P, Day NP, Diakite M, Djimde AA, Dondorp AM, Duong S, Edstein MD, Fairhurst RM, Faiz MA, Falade C, Flegg JA, Fogg C, Gonzalez R, Greenwood B, Guérin PJ, Guthmann JP, Hamed K, Hien TT, Htut Y, Juma E, Lim P, Mårtensson A, Mayxay M, Mokuolu OA, Moreira C, Newton P, Noedl H, Nosten F, Ogutu BR, Onyamboko MA, Owusu-Agyei S, Phyo AP, Premji Z, Price RN, Pukrittayakamee S, Ramharter M, Sagara I, Se Y, Suon S, Stepniewska K, Ward SA, White NJ, Winstanley PA.

Malar J. 2015 Sep 22;14:359. doi: 10.1186/s12936-015-0874-1.

9.

Use of health care reimbursement data to estimate vaccination coverage in France: Example of hepatitis B, meningitis C, and human papillomavirus vaccination.

Fonteneau L, Ragot M, Guthmann JP, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2015 Oct;63(5):293-8. doi: 10.1016/j.respe.2015.06.005. Epub 2015 Sep 18.

10.

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group, Adjuik MA, Allan R, Anvikar AR, Ashley EA, Ba MS, Barennes H, Barnes KI, Bassat Q, Baudin E, Björkman A, Bompart F, Bonnet M, Borrmann S, Brasseur P, Bukirwa H, Checchi F, Cot M, Dahal P, D'Alessandro U, Deloron P, Desai M, Diap G, Djimde AA, Dorsey G, Doumbo OK, Espié E, Etard JF, Fanello CI, Faucher JF, Faye B, Flegg JA, Gaye O, Gething PW, González R, Grandesso F, Guerin PJ, Guthmann JP, Hamour S, Hasugian AR, Hay SI, Humphreys GS, Jullien V, Juma E, Kamya MR, Karema C, Kiechel JR, Kremsner PG, Krishna S, Lameyre V, Ibrahim LM, Lee SJ, Lell B, Mårtensson A, Massougbodji A, Menan H, Ménard D, Menéndez C, Meremikwu M, Moreira C, Nabasumba C, Nambozi M, Ndiaye JL, Nikiema F, Nsanzabana C, Ntoumi F, Ogutu BR, Olliaro P, Osorio L, Ouédraogo JB, Penali LK, Pene M, Pinoges L, Piola P, Price RN, Roper C, Rosenthal PJ, Rwagacondo CE, Same-Ekobo A, Schramm B, Seck A, Sharma B, Sibley CH, Sinou V, Sirima SB, Smith JJ, Smithuis F, Somé FA, Sow D, Staedke SG, Stepniewska K, Swarthout TD, Sylla K, Talisuna AO, Tarning J, Taylor WR, Temu EA, Thwing JI, Tjitra E, Tine RC, Tinto H, Vaillant MT, Valecha N, Van den Broek I, White NJ, Yeka A, Zongo I.

BMC Med. 2015 Mar 31;13:66. doi: 10.1186/s12916-015-0301-z.

11.

Vaccine knowledge in students in Paris, France, and surrounding regions.

Mellon G, Rigal L, Partouche H, Aoun O, Jaury P, Joannard N, Guthmann JP, Cochereau D, Caumes E, Bricaire F, Salmon-Céron D.

Can J Infect Dis Med Microbiol. 2014 May;25(3):141-6.

12.

Validity of self-reported vaccination status among French healthcare students.

Loulergue P, Pulcini C, Massin S, Bernhard M, Fonteneau L, Levy-Brühl D, Guthmann JP, Launay O.

Clin Microbiol Infect. 2014 Dec;20(12):O1152-4. doi: 10.1111/1469-0691.12759. Epub 2014 Aug 11.

13.

[Low pneumococcal conjugated vaccine immunization coverage in low-income families: a study in Île-de-France].

Guthmann JP, Chauvin P, Le Strat Y, Soler M, Fonteneau L, Lévy-Bruhl D.

Arch Pediatr. 2014 Jun;21(6):584-92. doi: 10.1016/j.arcped.2014.03.012. Epub 2014 Apr 24. French.

PMID:
24768070
14.

Family history of immigration from a tuberculosis endemic country and low family income are associated with a higher BCG vaccination coverage in Ile-de-France region, France.

Guthmann JP, Chauvin P, Le Strat Y, Soler M, Fonteneau L, Lévy-Bruhl D.

Vaccine. 2013 Nov 19;31(48):5666-71. doi: 10.1016/j.vaccine.2013.09.059. Epub 2013 Oct 10.

PMID:
24120671
15.

Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey.

Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP; Studyvax survey group.

Vaccine. 2013 Jun 10;31(26):2835-8. doi: 10.1016/j.vaccine.2013.04.004. Epub 2013 Apr 24.

PMID:
23623864
16.

[Vaccination coverage in 6-year-old preschool children, France, 2005-2006].

Fonteneau L, Urcun JM, Guthmann JP, Collet M, Neulat N, Bristol-Gauzy P, Guignon N, Lévy-Bruhl D, Herbet JB.

Arch Pediatr. 2013 Mar;20(3):241-7. doi: 10.1016/j.arcped.2012.12.019. Epub 2013 Jan 30. French.

PMID:
23375080
17.

Vaccination coverage of health care personnel working in health care facilities in France: results of a national survey, 2009.

Guthmann JP, Fonteneau L, Ciotti C, Bouvet E, Pellissier G, Lévy-Bruhl D, Abiteboul D.

Vaccine. 2012 Jun 29;30(31):4648-54. doi: 10.1016/j.vaccine.2012.04.098. Epub 2012 May 10.

PMID:
22579863
18.

Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France.

Bone A, Guthmann JP, Assal A, Rousset D, Degeorges A, Morel P, Valette M, Enouf V, Jacquot E, Pelletier B, Le Strat Y, Pillonel J, Fonteneau L, van der Werf S, Lina B, Tiberghien P, Lévy-Bruhl D.

PLoS One. 2012;7(3):e33056. doi: 10.1371/journal.pone.0033056. Epub 2012 Mar 22.

19.

Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.

Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D.

Vaccine. 2012 Feb 1;30(6):995-7. doi: 10.1016/j.vaccine.2011.12.011. Epub 2011 Dec 15.

PMID:
22178520
20.

Susceptibility of health care students to measles, Paris, France.

Loulergue P, Guthmann JP, Fonteneau L, Armengaud JB, Levy-Brühl D, Launay O.

Emerg Infect Dis. 2011 Sep;17(9):1766-7. doi: 10.3201/eid1709.110141. No abstract available.

21.

Barriers to implementation of the new targeted BCG vaccination in France: a cross sectional study.

Rossignol L, Guthmann JP, Kernéis S, Aubin-Auger I, Lasserre A, Chauvin P, Pelat C, Hanslik T, Lévy-Bruhl D, Blanchon T.

Vaccine. 2011 Jul 18;29(32):5232-7. doi: 10.1016/j.vaccine.2011.05.020. Epub 2011 May 24.

PMID:
21609744
22.

Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France.

Guthmann JP, Antoine D, Fonteneau L, Che D, Lévy-Bruhl D.

Euro Surveill. 2011 Mar 24;16(12). pii: 19824.

23.

Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey.

Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, de Valk H, Lévy-Bruhl D.

BMC Public Health. 2011 Jan 12;11:30. doi: 10.1186/1471-2458-11-30.

24.

Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.

Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D.

Vaccine. 2010 Nov 29;28(51):8157-61. doi: 10.1016/j.vaccine.2010.09.096. Epub 2010 Oct 27.

PMID:
20937310
25.

Report of the 2nd "French Clinical Vaccinology Meeting Jean-Gerard Guillet": immunization and respiratory diseases.

Loulergue P, Burgel PR, Carrat F, Fritzell B, Guthmann JP, Locht C, Power UF, Varon E, Dusser D, Launay O.

Vaccine. 2010 Sep 14;28(40):6551-5. doi: 10.1016/j.vaccine.2010.07.038. Epub 2010 Jul 30.

PMID:
20674881
26.

[BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009].

Guthmann JP, Fonteneau L, Desplanques L, Lévy-Bruhl D.

Arch Pediatr. 2010 Sep;17(9):1281-7. doi: 10.1016/j.arcped.2010.05.013. Epub 2010 Jun 29. French.

PMID:
20591630
27.

[Factors associated with tetanus vaccination coverage in adults in France and with knowledge of vaccination status].

Guthmann JP, Fonteneau L, Antona D, Lévy-Bruhl D.

Med Mal Infect. 2010 Oct;40(10):560-7. doi: 10.1016/j.medmal.2010.03.009. Epub 2010 Apr 18. French.

PMID:
20400252
28.

Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey.

Vaux S, Noël D, Fonteneau L, Guthmann JP, Lévy-Bruhl D.

BMC Public Health. 2010 Mar 25;10:159. doi: 10.1186/1471-2458-10-159.

29.

In vivo parasitological measures of artemisinin susceptibility.

Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ.

J Infect Dis. 2010 Feb 15;201(4):570-9. doi: 10.1086/650301.

30.

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.

Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M.

Malar J. 2009 Aug 23;8:203. doi: 10.1186/1475-2875-8-203.

31.

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.

Bonnet M, Broek Iv, van Herp M, Urrutia PP, van Overmeir C, Kyomuhendo J, Ndosimao CN, Ashley E, Guthmann JP.

Malar J. 2009 Aug 10;8:192. doi: 10.1186/1475-2875-8-192.

32.

Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.

Pearce RJ, Pota H, Evehe MS, Bâ el-H, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cissé B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C.

PLoS Med. 2009 Apr 14;6(4):e1000055. doi: 10.1371/journal.pmed.1000055. Epub 2009 Apr 14.

33.

[Clinical research and humanitarian work: the role of Médecins sans Frontières in the fight against malaria].

Guthmann JP.

Med Sci (Paris). 2009 Mar;25(3):301-6. doi: 10.1051/medsci/2009253301. French.

34.

Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots.

Mérens A, Guérin PJ, Guthmann JP, Nicand E.

J Clin Microbiol. 2009 Jun;47(6):1931-3. doi: 10.1128/JCM.02245-08. Epub 2009 Apr 1.

35.

[BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].

Guthmann JP, de La Rocque F, Boucherat M, van Cauteren D, Fonteneau L, Lécuyer A, Cohen R, Lévy-Bruhl D.

Arch Pediatr. 2009 May;16(5):489-95. doi: 10.1016/j.arcped.2009.01.006. Epub 2009 Mar 21. French.

PMID:
19304464
36.

Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.

Ashley EA, Pinoges L, Turyakira E, Dorsey G, Checchi F, Bukirwa H, van den Broek I, Zongo I, Urruta PP, van Herp M, Balkan S, Taylor WR, Olliaro P, Guthmann JP.

Malar J. 2008 Aug 9;7:154. doi: 10.1186/1475-2875-7-154.

37.

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.

Guthmann JP, Checchi F, van den Broek I, Balkan S, van Herp M, Comte E, Bernal O, Kindermans JM, Venis S, Legros D, Guerin PJ.

PLoS Med. 2008 Aug 5;5(8):e169. doi: 10.1371/journal.pmed.0050169. No abstract available.

38.

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.

Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton P, Nosten F, Olliaro P, Osario L, Pinoges L, Price R, Rowland M, Smithuis F, Taylor R, White NJ.

Malar J. 2008 Aug 2;7:149. doi: 10.1186/1475-2875-7-149.

39.

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.

Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radiguès X, Nosten F.

Trop Med Int Health. 2008 Jan;13(1):91-8. doi: 10.1111/j.1365-3156.2007.01978.x.

40.

Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment.

Olliaro P, Pinoges L, Checchi F, Vaillant M, Guthmann JP.

Trop Med Int Health. 2008 Jan;13(1):83-90. doi: 10.1111/j.1365-3156.2007.01977.x.

41.

Use of Lot Quality Assurance Sampling (LQAS) to estimate vaccination coverage helps guide future vaccination efforts.

Alberti KP, Guthmann JP, Fermon F, Nargaye KD, Grais RF.

Trans R Soc Trop Med Hyg. 2008 Mar;102(3):251-4. doi: 10.1016/j.trstmh.2007.10.015.

PMID:
18178230
42.

Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria.

Fogg C, Twesigye R, Batwala V, Piola P, Nabasumba C, Kiguli J, Mutebi F, Hook C, Guillerm M, Moody A, Guthmann JP.

Trans R Soc Trop Med Hyg. 2008 Jan;102(1):25-31. Epub 2007 Nov 26.

PMID:
18031779
43.
44.

Don't spin the pen: two alternative methods for second-stage sampling in urban cluster surveys.

Grais RF, Rose AM, Guthmann JP.

Emerg Themes Epidemiol. 2007 Jun 1;4:8.

46.

Death rates from malaria epidemics, Burundi and Ethiopia.

Guthmann JP, Bonnet M, Ahoua L, Dantoine F, Balkan S, van Herp M, Tamrat A, Legros D, Brown V, Checchi F.

Emerg Infect Dis. 2007 Jan;13(1):140-3.

47.

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.

Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ.

J Infect Dis. 2007 Apr 1;195(7):927-33. Epub 2007 Feb 26.

PMID:
17330781
48.

Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.

Mugittu K, Priotto G, Guthmann JP, Kiguli J, Adjuik M, Snounou G, Beck HP, Mshinda H, Olliaro PL, Taylor WR.

Trop Med Int Health. 2007 Feb;12(2):219-23.

49.

Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad.

Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A, Nargaye KD, Coker J, Alberti KP, Cochet A, Ihekweazu C, Nathan N, Payne L, Porten K, Sauvageot D, Schimmer B, Fermon F, Burny ME, Hersh BS, Guerin PJ.

PLoS Med. 2007 Jan;4(1):e16.

50.

Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004.

Checchi F, Cox J, Balkan S, Tamrat A, Priotto G, Alberti KP, Guthmann JP.

Emerg Infect Dis. 2006 Oct;12(10):1477-85.

Supplemental Content

Loading ...
Support Center